Saturday 7 November 2026 Export SLDB’s income statement to Excel — free account

Solid Biosciences Inc.

SLDB Healthcare Biotechnology

Solid Biosciences Inc.’s revenue for fiscal 2022 (year ended December 2022) was $8.1 million.

EPS: +25.6%
Free cash flow: −39.6%

Quarter to September 2026, against a year earlier

6.57 0.39 +6.31%

Follow SLDB

Alert me

Market cap: $662.7M
P/E: 0.0×
Fwd P/E: −2.4×
Dividend yield: —
F-score: n/a
Altman Z: −2.87
Beneish M: n/a
Dividend safety: n/a

Overview

	Older periods	Dec '25	Mar '26	Jun '26	Sep '26
P/E ratio Full definition →	+8 more quarters Free account	—	—	—	—
EV/Sales Full definition →		—	—	—	—
EV/FCF Full definition →		—	—	—	—
Quick Ratio Full definition →		5.65	12.59	13.24	11.48
Current Ratio Full definition →		6.14	13.10	13.82	11.99
Net Debt/EBITDA Full definition →		3.81	6.63	6.48	5.96
Debt/Assets Full definition →		0.00%	0.00%	0.00%	0.00%
Debt/Equity Full definition →		0.00	0.00	0.00	0.00
Asset Turnover Full definition →		0.00	0.00	0.00	0.00
Operating CF/Net income Full definition →		1.08	0.83	0.96	0.84
Capex/Depreciation Full definition →		1.71	0.74	0.15	0.48
Interest Coverage Full definition →		(9,880.60)	—	—	—
Research and Development Expense of Revenue Full definition →		0.00%	0.00%	0.00%	0.00%
Selling, General and Administrative Expense of Revenue Full definition →		0.00%	0.00%	0.00%	0.00%
Intangible Assets out of Total Assets Full definition →		0.00	0.00	0.00	0.00
Share Based Compensation of Revenue Full definition →		0.00%	0.00%	0.00%	0.00%
Free Cash Flow Yield Full definition →		—	—	—	—
Revenue per Share Full definition →		0.00	0.00	0.00	0.00
Operating CF per Share Full definition →		(0.61)	(0.43)	(0.37)	(0.30)
Capex per Share Full definition →		(0.01)	0.00	0.00	0.00
Free Cash Flow per Share Full definition →		(0.62)	(0.43)	(0.37)	(0.30)
Cash per Share Full definition →		2.16	3.47	2.63	2.31
Shareholders Equity per Share Full definition →		2.06	3.41	2.60	2.27
Interest Debt per Share Full definition →		0.00	0.00	0.00	0.00
Book value per Share Full definition →		2.06	3.41	2.60	2.27
Free Cash Flow Full definition →		(54.03)	(47.39)	(52.74)	(46.04)
Working Capital Full definition →		171.98	366.51	366.52	334.74
Capital Expenditures Full definition →		(0.48)	(0.16)	(0.15)	(0.50)
Net Current Asset Value Full definition →		152.93	348.03	348.60	317.40
EV/EBIT Full definition →		—	—	—	—
Capex to Sales Full definition →		0.00	0.00	0.00	0.00
Other line items
Average Payables Full definition →		3.73	6.00	4.53	5.83
Average Assets Full definition →		210.60	383.40	364.44	331.91
Average Common Equity Full definition →		158.63	334.30	316.18	280.03

Show all line items

Columns are period end dates · fundamentals updated 6 Nov 2026

Stockrow Weekly